PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 60 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $338,000 | -13.3% | 400,000 | 0.0% | 0.01% | -7.1% |
| Q2 2019 | $390,000 | -22.6% | 400,000 | 0.0% | 0.01% | -26.3% |
| Q1 2019 | $504,000 | -61.1% | 400,000 | 0.0% | 0.02% | -68.9% |
| Q4 2018 | $1,296,000 | -1.4% | 400,000 | -15.1% | 0.06% | +19.6% |
| Q2 2018 | $1,315,000 | -59.0% | 471,321 | -30.2% | 0.05% | -62.8% |
| Q1 2018 | $3,206,000 | -18.5% | 675,000 | 0.0% | 0.14% | -23.5% |
| Q4 2017 | $3,935,000 | +316.4% | 675,000 | +50.0% | 0.18% | +306.8% |
| Q3 2017 | $945,000 | -55.1% | 450,000 | 0.0% | 0.04% | -58.5% |
| Q2 2017 | $2,106,000 | -40.2% | 450,000 | 0.0% | 0.11% | -47.8% |
| Q1 2017 | $3,519,000 | -36.2% | 450,000 | 0.0% | 0.20% | -45.0% |
| Q4 2016 | $5,517,000 | -21.4% | 450,000 | 0.0% | 0.37% | -16.1% |
| Q3 2016 | $7,016,000 | +39.4% | 450,000 | +8.4% | 0.44% | +18.0% |
| Q2 2016 | $5,034,000 | +11.1% | 415,000 | -11.7% | 0.37% | -1.8% |
| Q1 2016 | $4,531,000 | – | 470,000 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,350,000 | $36,636,000 | 4.04% |
| EcoR1 Capital, LLC | 602,315 | $9,390,000 | 2.88% |
| NEA Management Company, LLC | 3,556,778 | $55,450,000 | 2.49% |
| Opaleye Management Inc. | 152,000 | $2,370,000 | 1.24% |
| Avoro Capital Advisors LLC | 179,565 | $2,799,000 | 0.49% |
| Monashee Investment Management LLC | 85,000 | $1,325,000 | 0.47% |
| Rock Springs Capital Management LP | 450,000 | $7,016,000 | 0.44% |
| Perceptive Advisors | 344,550 | $5,372,000 | 0.35% |
| Hillhouse Capital Management | 763,790 | $11,907,000 | 0.24% |
| Eventide Asset Management | 220,000 | $3,430,000 | 0.21% |